Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction
Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.